| Entry |
|
|---|
| Name |
Taurine (JP18/USP/INN);
Aminoethylsulfonic acid (JAN);
Taurine (TN) |
|---|
| Formula |
C2H7NO3S
|
|---|
| Exact mass |
125.0147
|
|---|
| Mol weight |
125.15
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Remark |
|
|---|
| Efficacy |
Liver function improving agent |
|---|
| Brite |
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
119 Miscellaneous
1190 Miscellaneous
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2119 Others
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
3 Agents affecting metabolism
39 Other agents affecting metabolism
391 Liver disease agents
3919 Others
D00047 Taurine (JP18/USP/INN); Aminoethylsulfonic acid (JAN)
Classification of Japanese OTC drugs [BR:br08313]
Agents for ophthalmologic use
62 General eye drops
D00047 Taurine (JP18/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Aminoethylsulfonic acid; Taurine
D00047 Taurine (JP18/USP/INN)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00047 Taurine
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 7
1 C1b C 26.2740 -17.4876
2 S4a S 27.4853 -16.7889
3 C1b C 25.0570 -16.7889
4 O1d O 28.6964 -17.4876
5 N1a N 23.8459 -17.4876
6 O1d O 28.6152 -15.9389
7 O1d O 26.2729 -16.0889
BOND 6
1 1 2 1
2 1 3 1
3 2 4 1
4 3 5 1
5 2 6 2
6 2 7 2
|
|---|
